GlaxoSmithKline

FDA inspection history in Conshohocken, Pennsylvania, 2018 to 2024

2
Form 483s

Every document, by year

  • Form 483

2018: one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018One Form 483, at Conshohocken, Pennsylvania.
  2. 2024One Form 483, at Conshohocken, Pennsylvania.
  3. 2024The longest 483 on file: 5 observations over 6 pages at Conshohocken, Pennsylvania.

Cited most

Across all GlaxoSmithKline observations on file

The complete GlaxoSmithKline file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2024-09-25483 Form 483$99
2018-01-26483 Form 483$99

FEI number 3004055938 · most recent document Sep 25, 2024

About GlaxoSmithKline

How many FDA Form 483s has GlaxoSmithKline received?

FDA Intel has 2 Form 483s on file for GlaxoSmithKline; the most recent is dated Sep 25, 2024.

When was GlaxoSmithKline last inspected by FDA?

The most recent FDA inspection document on file for GlaxoSmithKline is a Form 483 dated Sep 25, 2024, for the site in Conshohocken, Pennsylvania.

What did FDA cite at GlaxoSmithKline?

The regulations cited most in the observations on file for GlaxoSmithKline are 21 CFR 211.22 (Responsibilities of quality control unit), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.160 (General requirements), 1 time.